# Voyageur Pharmaceuticals Confirms Pharmaceutical-Grade Purity of Barite from Frances Creek and Progresses to Health Canada Human Trial with Alberta Innovates Grant; Announces Stock Option and DSU grants, and Proposed Issuance of Securities for Debt

Canonical Atlas analysis: https://atlas-staging.minestarters.com/news/voyageur-pharmaceuticals-confirms-pharmaceutical-grade-purity-of-barite-from-fra--60ff2ab8-9fd3-4257-a1cc-97e77b8d5484

Original source: https://money.tmx.com/en/quote/VM/news/5469291407965030/voyageur-pharmaceuticals-confirms-pharmaceutical-grade-purity-of-barite-from-fra

Publisher: tmx

Original announcement: 2026-03-04T12:00:00.000Z

Analysis by Minestarters Atlas

Atlas analysis published: Unknown date

Atlas analysis updated: Unknown date

- Company: Voyageur Pharmaceuticals Ltd.

- Ticker: VM

- Exchange: TSX

- Region: British Columbia

- Primary commodity: Barium

- Secondary commodities: Iodine

- Document categories: Metallurgy, Other

- Extracted: 2026-08-21 01:27:37 UTC

Narrative sentiment: 0.80 · Bullish

## Minestarters Atlas summary

Voyageur Pharmaceuticals has confirmed that its Frances Creek barite meets pharmaceutical-grade purity standards, with an average BaSO4 assay of 98.8%. The company is progressing toward Health Canada human trials and has secured non-dilutive funding through the Alberta Innovates program.

Reasoning: The company confirmed pharmaceutical-grade purity for its barite API, a major technical milestone for its vertically integrated business model.

- Positive factor: High purity results \(98.8% average\) exceeding USP standards

- Positive factor: Successful micronization to ultra-fine particle sizes

- Positive factor: De-risking milestone for pharmaceutical-grade API

- Positive factor: Non-dilutive funding support from Alberta Innovates

- Negative factor: Upcoming clinical trials represent significant regulatory risk

Facts used in scoring: 2

## Classification and evidence

**Free Milling**

Polarity: positive

Definition: Simple, clean ore amenable to standard processing without oxidation.

Why it applies: The material processes efficiently into ultra-fine particles with high yield and purity.

Evidence · text

> demonstrated that the material processes efficiently into ultra-fine particles

**QA/QC Disclosed**

Polarity: positive

Story-specific tag

Definition: Release includes QA/QC disclosure — certified lab, QP sign-off, or stated methods \(blanks, standards, duplicates\).

Why it applies: Testing was completed by SGS Laboratories and met USP monograph requirements.

Evidence · text

> Testing by SGS Laboratories... confirmed purity, with % BaSO4 assay results ranging from 98.1% to 99.4%

## Extracted facts

Stored fact records: 2. Some facts used in scoring do not have a stored record.

## Metallurgical Results (2)

### assay

[Link to this fact](https://atlas-staging.minestarters.com/news/voyageur-pharmaceuticals-confirms-pharmaceutical-grade-purity-of-barite-from-fra--60ff2ab8-9fd3-4257-a1cc-97e77b8d5484#fact-metallurgical-facts-0)

barium

#### Identity

- Commodity: barium
- Ticker: VM

#### Test Work

- Program Status: detailed
- Test Type: assay
- Processing Route: controlled acid-wash procedure
- Sample: Frances Creek barium sulfate API samples

#### Recovery

- Head Grade: 98.8
- Head Grade Unit: %

#### Lab

- Laboratory: SGS Laboratories

#### Review

- Needs Review: No
- Historical: No

#### Dates

- Event date: 2026-03-04T00:00:00.000Z

Reasoning: Average purity of 98.8% BaSO4 is exceptionally high and meets pharmaceutical standards.

- Positive factor: Purity exceeds USP monograph requirement of 97.5%

Evidence · text

> average grade of 98.8%

### micronization

[Link to this fact](https://atlas-staging.minestarters.com/news/voyageur-pharmaceuticals-confirms-pharmaceutical-grade-purity-of-barite-from-fra--60ff2ab8-9fd3-4257-a1cc-97e77b8d5484#fact-metallurgical-facts-1)

barium

#### Identity

- Commodity: barium
- Ticker: VM

#### Test Work

- Test Type: micronization
- Sample: micronized barite

#### Recovery

- Recovery: 100 %

#### Review

- Needs Review: No
- Historical: No

#### Dates

- Event date: 2026-03-04T00:00:00.000Z

Reasoning: Successful processing into ultra-fine particles with 100% yield.

- Positive factor: 100% yield achieved during micronization

Evidence · text

> exhibited good flowability, 100% yield

## How Atlas produces this analysis

Minestarters Atlas uses automated extraction to summarize mining announcements, identify reported measurements, and classify supporting evidence. Sentiment reflects the extracted narrative and classification rules; it is an interpretation, not a reported measurement. Evidence quotes and context are provided where available. Missing data, low-confidence results, and review flags indicate limitations. Check the original publisher announcement before relying on an interpretation.